After being viewed as a candidate gene for energy homeostasis and a determinant of obesity-related traits, SGIP1 was identified as an ortholog of FCHo1/2 and thus was thought to play a role in CME (Uezu et al., 2007; Hollopeter et al., 2014). Here, SGIP1 is linked to obesity disorder.